Guidance on the use of H2 antagonists for the prevention and management of hypersensitivity

To guide for members on the prevention and management of hypersensitivity in situations where H2 antagonists are in short supply or unavailable

BOPA Guidance on use of H2 antagonists for hypersensitivity June 2020 Version 1.0

File type: application/pdf

Download resource

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

New Resources

Last reviewed: 2020-06-25 08:55:59 by Netty Cracknell

BOPA Paclitaxel HSR SE PROTOCOL v1.0

Other

View resources
Last reviewed: 2020-06-25 08:55:10 by Netty Cracknell

BOPA instructions for Paclitaxel HSR SE v1.0

View resources
Last reviewed: 2020-06-17 08:26:17 by Joseph Williams

BOPA Executive Committee TCON Minutes – May 2020

Minutes

View resources

23rd BOPA Symposium 2020

Friday 9th to Sunday 11th October 2020 – VIRTUAL

Everything you need to know